marketcap
Biohaven Pharmaceutical Holding Company Ltd. BHVN
$ 45.32
0.29%
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q2
added 12-16-2023
Biohaven Pharmaceutical Holding Company Ltd. Balance Sheet 2011-2024 | BHVN
Annual Balance Sheet Biohaven Pharmaceutical Holding Company Ltd.
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
455 M | 136 M | - | -147 M | - | -18.8 M | -1.46 M | - | - | - | - |
Long Term Debt |
627 M | 267 M | - | 118 M | - | 595 K | - | - | - | - | - |
Long Term Debt Current |
- | 675 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | 802 M | 286 M | 120 M | 5.49 M | 1.9 M | 476 K | - | - | - | - |
Total Current Liabilities |
534 M | 278 M | 66.2 M | 19.5 M | 9.43 M | - | - | - | - | - | - |
Total Liabilities |
1.76 B | 1.02 B | 352 M | 139 M | 14.9 M | 9.84 M | 805 K | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.59 B | -1.74 B | -972 M | -444 M | -203 M | -75.5 M | -11.8 M | - | - | - | - |
Total Assets |
1.08 B | 687 M | 344 M | 290 M | 147 M | 27 M | 1.89 M | - | - | - | - |
Cash and Cash Equivalents |
172 M | 132 M | 317 M | 264 M | 131 M | 23.6 M | 1.46 M | - | - | - | - |
Book Value |
-683 M | -332 M | -7.42 M | 151 M | 132 M | 17.2 M | 1.09 M | - | - | - | - |
Total Shareholders Equity |
-739 M | -390 M | -7.42 M | 151 M | 132 M | -45 M | 1.09 M | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Biohaven Pharmaceutical Holding Company Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | 765 M | 634 M | 627 M | 619 M | 274 M | 271 M | 267 M | 264 M | 267 M | 267 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | 2.19 B | 1.84 B | 1.76 B | 1.66 B | 1.24 B | 1.22 B | 1.02 B | 936 M | 460 M | 411 M | 352 M | 352 M | 352 M | 352 M | 139 M | 139 M | 139 M | 139 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | -3.14 B | -2.7 B | -2.59 B | -2.39 B | -2.21 B | -2 B | -1.74 B | -1.52 B | -1.33 B | -1.15 B | -972 M | -972 M | -972 M | -972 M | -444 M | -444 M | -444 M | -444 M | -203 M | -203 M | -203 M | -203 M | -75.5 M | -75.5 M | -75.5 M | -75.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | 1.39 B | 1.37 B | 1.08 B | 1.13 B | 846 M | 1 B | 687 M | 782 M | 424 M | 533 M | 344 M | 344 M | 344 M | 344 M | 290 M | 290 M | 290 M | 290 M | 147 M | 147 M | 147 M | 147 M | 27 M | 27 M | 27 M | 27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 169 M | 172 M | 501 M | 306 M | 465 M | 132 M | 132 M | 132 M | 132 M | 317 M | 317 M | 317 M | 317 M | 264 M | 264 M | 264 M | 264 M | 131 M | 131 M | 131 M | 131 M | 23.7 M | 23.6 M | 23.6 M | 23.6 M | 1.46 M | - | - | - | 1.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | -806 M | -466 M | -683 M | -531 M | -397 M | -218 M | -332 M | -154 M | -35.5 M | 122 M | -7.42 M | -7.42 M | -7.42 M | -7.42 M | 151 M | 151 M | 151 M | 151 M | 132 M | 132 M | 132 M | 132 M | -1.76 M | -1.76 M | -1.76 M | -1.76 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | -801 M | -466 M | -739 M | -588 M | -457 M | -278 M | -390 M | -214 M | -35.5 M | -390 M | -7.42 M | -7.42 M | -7.42 M | -7.42 M | 151 M | 151 M | 151 M | 151 M | 132 M | 156 M | 193 M | -53.5 M | -45 M | -45 M | -45 M | -45 M | 1.09 M | - | - | - | 1.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency